| Device |
reagent red blood cells |
| Regulation Description |
Reagent Red Blood Cells. |
| Definition |
For the detection of or identification of human blood-group antibodies |
| Physical State |
Sourced from human blood |
| Technical Method |
Antigen and antibody reaction by hemagglutination, column agglutination (gel technique), solid phase or microplate |
| Target Area |
Serum or plasma |
| Regulation Medical Specialty |
Hematology |
| Review Panel |
Hematology |
| Product Code | QHT |
| Premarket Review |
Center for Biologics Evaluation & Research (CBER)
|
|
Unclassified Reason
|
Pre-Amendment
|
| Submission Type |
Contact ODE
|
| Regulation Number |
660.30
|
| Device Class |
Unclassified
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
| Implanted Device? |
No
|
| Life-Sustain/Support Device? |
No
|
| Third Party Review |
Not Third Party Eligible |
|
|